Conquering Diseases

A Study Of An Investigational Drug In Adults With Primary Progressive Multiple Sclerosis

Description

Seeking men and women 18 years of age or older with primary progressive multiple sclerosis for participation in a study of an investigational drug called Ocrelizumab

Overview

We are studying the effects if a drug named ocrelizumab at higher doses than currently approved for patients with primary progressive multiple sclerosis (PPMS).

What we're hoping for

To evaluate the safety and efficacy of higher doses of ocrelizumab in patients with primary progressive multiple sclerosis (PPMS) and whether a higher dose can slow down the progression and worsening of PPMS.

Additional Information

ClinicalTrials.gov Identifier: NCT04548999

 Principal Investigator

Carolina  Ionete, MD

UMass Memorial Health Care

 Study Contact

Mugdha  Deshpande

mugdha.deshpande@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989